Since more than 75% of ERBB2 fusions were accompanied by ERBB2 amplification, we also analyzed the difference in CNV values between the pure ERBB2 amplification (ERBB2 Amp) and ERBB2 amplification combined with fusion (ERBB2 Fusion + Amp) in different cancer types. The gene discussed is ERBB2; the disease is cancer.